AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to President Biden’s remarks today about the need to lower prescription drug prices

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement about Medicare enrollees soon having access to at-home COVID tests at no cost:

AARP CEO Jo Ann Jenkins issued the following statement reacting to the announcement of a deal to lower prescription drug costs

AARP Chief Executive Officer Jo Ann Jenkins released the following statement in response to today’s announcement of the 2022 cost-of-living adjustment (COLA) in Social Security benefits

AARP has launched a full-scale campaign, including a $4 million ad buy, pushing back on false claims from the pharmaceutical industry that reforms would limit Americans’ access to medicines. AARP has called for fair drug prices for years and is urging Congress to pass legislation that would allow Medicare to negotiate drug prices, put a cap on out-of-pocket costs that older adults pay for their prescription drugs and impose penalties on drug companies that raise prices faster than the rate of inflation.